Home > > > Report Detail

Global Next-Generation Biomanufacturing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 05-Dec-2022
No. of pages: 108
Inquire Before Buying

The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Next-Generation Biomanufacturing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Next-Generation Biomanufacturing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Next-Generation Biomanufacturing include Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, GEA Group, bbi-biotech, Esco Group of Companies and Solaris Biotechnology, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Next-Generation Biomanufacturing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Next-Generation Biomanufacturing market. Further, it explains the major drivers and regional dynamics of the global Next-Generation Biomanufacturing market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Merck

- Thermo Fisher Scientific

- Danaher

- Eppendorf

- Sartorius

- GEA Group

- bbi-biotech

- Esco Group of Companies

- Solaris Biotechnology

- PBS Biotech

- Applikon Biotechnology

- Meissner Filtration Products

- Shanghai Bailun Biotechnology

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Next-Generation Biomanufacturing Segment by Type

- Upstream Biomanufacturing

- Downstream Biomanufacturing

Next-Generation Biomanufacturing Segment by Application

- Biopharmaceutical Companies

- CMOs/CDMOs

- Research Institutions

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Next-Generation Biomanufacturing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Next-Generation Biomanufacturing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Next-Generation Biomanufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next-Generation Biomanufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next-Generation Biomanufacturing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Next-Generation Biomanufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Next-Generation Biomanufacturing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, GEA Group, bbi-biotech, Esco Group of Companies and Solaris Biotechnology, etc.

Global Next-Generation Biomanufacturing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Biomanufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Upstream Biomanufacturing
1.2.3 Downstream Biomanufacturing
1.3 Market by Application
1.3.1 Global Next-Generation Biomanufacturing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Biopharmaceutical Companies
1.3.3 CMOs/CDMOs
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Next-Generation Biomanufacturing Market Size (2017-2028)
2.2 Next-Generation Biomanufacturing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Next-Generation Biomanufacturing Market Size by Region (2017-2022)
2.4 Global Next-Generation Biomanufacturing Market Size Forecast by Region (2023-2028)
2.5 Global Top Next-Generation Biomanufacturing Countries Ranking by Market Size
3 Next-Generation Biomanufacturing Competitive by Company
3.1 Global Next-Generation Biomanufacturing Revenue by Players
3.1.1 Global Next-Generation Biomanufacturing Revenue by Players (2017-2022)
3.1.2 Global Next-Generation Biomanufacturing Market Share by Players (2017-2022)
3.2 Global Next-Generation Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Next-Generation Biomanufacturing Revenue
3.4 Global Next-Generation Biomanufacturing Market Concentration Ratio
3.4.1 Global Next-Generation Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Biomanufacturing Revenue in 2021
3.5 Global Next-Generation Biomanufacturing Key Players Head office and Area Served
3.6 Key Players Next-Generation Biomanufacturing Product Solution and Service
3.7 Date of Enter into Next-Generation Biomanufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Next-Generation Biomanufacturing Breakdown Data by Type
4.1 Global Next-Generation Biomanufacturing Historic Revenue by Type (2017-2022)
4.2 Global Next-Generation Biomanufacturing Forecasted Revenue by Type (2023-2028)
5 Global Next-Generation Biomanufacturing Breakdown Data by Application
5.1 Global Next-Generation Biomanufacturing Historic Market Size by Application (2017-2022)
5.2 Global Next-Generation Biomanufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next-Generation Biomanufacturing Revenue by Company (2020-2022)
6.2 North America Next-Generation Biomanufacturing Revenue by Type (2017-2028)
6.3 North America Next-Generation Biomanufacturing Revenue by Application (2017-2028)
6.4 North America Next-Generation Biomanufacturing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Next-Generation Biomanufacturing Revenue by Company (2020-2022)
7.2 Europe Next-Generation Biomanufacturing Revenue by Type (2017-2028)
7.3 Europe Next-Generation Biomanufacturing Revenue by Application (2017-2028)
7.4 Europe Next-Generation Biomanufacturing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Next-Generation Biomanufacturing Revenue by Company (2020-2022)
8.2 Asia Pacific Next-Generation Biomanufacturing Revenue by Type (2017-2028)
8.3 Asia Pacific Next-Generation Biomanufacturing Revenue by Application (2017-2028)
8.4 Asia Pacific Next-Generation Biomanufacturing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Next-Generation Biomanufacturing Revenue by Company (2020-2022)
9.2 Latin America Next-Generation Biomanufacturing Revenue by Type (2017-2028)
9.3 Latin America Next-Generation Biomanufacturing Revenue by Application (2017-2028)
9.4 Latin America Next-Generation Biomanufacturing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Next-Generation Biomanufacturing Revenue by Company (2020-2022)
10.2 Middle East and Africa Next-Generation Biomanufacturing Revenue by Type (2017-2028)
10.3 Middle East and Africa Next-Generation Biomanufacturing Revenue by Application (2017-2028)
10.4 Middle East and Africa Next-Generation Biomanufacturing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Next-Generation Biomanufacturing Products and Services
11.1.4 Merck Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.1.5 Merck Next-Generation Biomanufacturing SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next-Generation Biomanufacturing Products and Services
11.2.4 Thermo Fisher Scientific Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.2.5 Thermo Fisher Scientific Next-Generation Biomanufacturing SWOT Analysis
11.2.6 Thermo Fisher Scientific Recent Developments
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Next-Generation Biomanufacturing Products and Services
11.3.4 Danaher Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.3.5 Danaher Next-Generation Biomanufacturing SWOT Analysis
11.3.6 Danaher Recent Developments
11.4 Eppendorf
11.4.1 Eppendorf Company Details
11.4.2 Eppendorf Business Overview
11.4.3 Eppendorf Next-Generation Biomanufacturing Products and Services
11.4.4 Eppendorf Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.4.5 Eppendorf Next-Generation Biomanufacturing SWOT Analysis
11.4.6 Eppendorf Recent Developments
11.5 Sartorius
11.5.1 Sartorius Company Details
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Next-Generation Biomanufacturing Products and Services
11.5.4 Sartorius Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.5.5 Sartorius Next-Generation Biomanufacturing SWOT Analysis
11.5.6 Sartorius Recent Developments
11.6 GEA Group
11.6.1 GEA Group Company Details
11.6.2 GEA Group Business Overview
11.6.3 GEA Group Next-Generation Biomanufacturing Products and Services
11.6.4 GEA Group Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.6.5 GEA Group Next-Generation Biomanufacturing SWOT Analysis
11.6.6 GEA Group Recent Developments
11.7 bbi-biotech
11.7.1 bbi-biotech Company Details
11.7.2 bbi-biotech Business Overview
11.7.3 bbi-biotech Next-Generation Biomanufacturing Products and Services
11.7.4 bbi-biotech Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.7.5 bbi-biotech Next-Generation Biomanufacturing SWOT Analysis
11.7.6 bbi-biotech Recent Developments
11.8 Esco Group of Companies
11.8.1 Esco Group of Companies Company Details
11.8.2 Esco Group of Companies Business Overview
11.8.3 Esco Group of Companies Next-Generation Biomanufacturing Products and Services
11.8.4 Esco Group of Companies Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.8.5 Esco Group of Companies Next-Generation Biomanufacturing SWOT Analysis
11.8.6 Esco Group of Companies Recent Developments
11.9 Solaris Biotechnology
11.9.1 Solaris Biotechnology Company Details
11.9.2 Solaris Biotechnology Business Overview
11.9.3 Solaris Biotechnology Next-Generation Biomanufacturing Products and Services
11.9.4 Solaris Biotechnology Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.9.5 Solaris Biotechnology Next-Generation Biomanufacturing SWOT Analysis
11.9.6 Solaris Biotechnology Recent Developments
11.10 PBS Biotech
11.10.1 PBS Biotech Company Details
11.10.2 PBS Biotech Business Overview
11.10.3 PBS Biotech Next-Generation Biomanufacturing Products and Services
11.10.4 PBS Biotech Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.10.5 PBS Biotech Next-Generation Biomanufacturing SWOT Analysis
11.10.6 PBS Biotech Recent Developments
11.11 Applikon Biotechnology
11.11.1 Applikon Biotechnology Company Details
11.11.2 Applikon Biotechnology Business Overview
11.11.3 Applikon Biotechnology Next-Generation Biomanufacturing Products and Services
11.11.4 Applikon Biotechnology Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.11.5 Applikon Biotechnology Recent Developments
11.12 Meissner Filtration Products
11.12.1 Meissner Filtration Products Company Details
11.12.2 Meissner Filtration Products Business Overview
11.12.3 Meissner Filtration Products Next-Generation Biomanufacturing Products and Services
11.12.4 Meissner Filtration Products Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.12.5 Meissner Filtration Products Recent Developments
11.13 Shanghai Bailun Biotechnology
11.13.1 Shanghai Bailun Biotechnology Company Details
11.13.2 Shanghai Bailun Biotechnology Business Overview
11.13.3 Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Products and Services
11.13.4 Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022)
11.13.5 Shanghai Bailun Biotechnology Recent Developments
12 Next-Generation Biomanufacturing Market Dynamics
12.1 Next-Generation Biomanufacturing Market Trends
12.2 Next-Generation Biomanufacturing Market Drivers
12.3 Next-Generation Biomanufacturing Market Challenges
12.4 Next-Generation Biomanufacturing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Next-Generation Biomanufacturing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Upstream Biomanufacturing
Table 3. Key Players of Downstream Biomanufacturing
Table 4. Global Next-Generation Biomanufacturing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Next-Generation Biomanufacturing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Next-Generation Biomanufacturing Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Next-Generation Biomanufacturing Revenue Market Share by Region (2017-2022)
Table 8. Global Next-Generation Biomanufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Next-Generation Biomanufacturing Market Share by Players (2017-2022)
Table 10. Global Top Next-Generation Biomanufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Biomanufacturing as of 2021)
Table 11. Ranking of Global Top Next-Generation Biomanufacturing Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Next-Generation Biomanufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Next-Generation Biomanufacturing Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Next-Generation Biomanufacturing Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Next-Generation Biomanufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Next-Generation Biomanufacturing Revenue Market Share by Type (2017-2022)
Table 19. Global Next-Generation Biomanufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Next-Generation Biomanufacturing Revenue Market Share by Type (2023-2028)
Table 21. Global Next-Generation Biomanufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Next-Generation Biomanufacturing Revenue Market Share by Application (2017-2022)
Table 23. Global Next-Generation Biomanufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Next-Generation Biomanufacturing Revenue Market Share by Application (2023-2028)
Table 25. North America Next-Generation Biomanufacturing Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Next-Generation Biomanufacturing Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Next-Generation Biomanufacturing Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Next-Generation Biomanufacturing Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Next-Generation Biomanufacturing Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Next-Generation Biomanufacturing Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Next-Generation Biomanufacturing Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Next-Generation Biomanufacturing Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Next-Generation Biomanufacturing Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Next-Generation Biomanufacturing Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Next-Generation Biomanufacturing Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Next-Generation Biomanufacturing Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Next-Generation Biomanufacturing Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Next-Generation Biomanufacturing Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Next-Generation Biomanufacturing Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Next-Generation Biomanufacturing Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Next-Generation Biomanufacturing Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Next-Generation Biomanufacturing Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Next-Generation Biomanufacturing Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Next-Generation Biomanufacturing Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Next-Generation Biomanufacturing Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Next-Generation Biomanufacturing Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Next-Generation Biomanufacturing Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Next-Generation Biomanufacturing Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Next-Generation Biomanufacturing Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Next-Generation Biomanufacturing Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Next-Generation Biomanufacturing Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Next-Generation Biomanufacturing Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Next-Generation Biomanufacturing Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Next-Generation Biomanufacturing Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Next-Generation Biomanufacturing Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Next-Generation Biomanufacturing Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Next-Generation Biomanufacturing Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Next-Generation Biomanufacturing Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Next-Generation Biomanufacturing Revenue by Country (2023-2028) & (US$ Million)
Table 60. Merck Company Details
Table 61. Merck Business Overview
Table 62. Merck Next-Generation Biomanufacturing Product and Services
Table 63. Merck Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 64. Merck Next-Generation Biomanufacturing SWOT Analysis
Table 65. Merck Recent Developments
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Next-Generation Biomanufacturing Product and Services
Table 69. Thermo Fisher Scientific Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 70. Thermo Fisher Scientific Next-Generation Biomanufacturing SWOT Analysis
Table 71. Thermo Fisher Scientific Recent Developments
Table 72. Danaher Company Details
Table 73. Danaher Business Overview
Table 74. Danaher Next-Generation Biomanufacturing Product and Services
Table 75. Danaher Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 76. Danaher Next-Generation Biomanufacturing SWOT Analysis
Table 77. Danaher Recent Developments
Table 78. Eppendorf Company Details
Table 79. Eppendorf Business Overview
Table 80. Eppendorf Next-Generation Biomanufacturing Product and Services
Table 81. Eppendorf Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 82. Eppendorf Next-Generation Biomanufacturing SWOT Analysis
Table 83. Eppendorf Recent Developments
Table 84. Sartorius Company Details
Table 85. Sartorius Business Overview
Table 86. Sartorius Next-Generation Biomanufacturing Product and Services
Table 87. Sartorius Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 88. Sartorius Next-Generation Biomanufacturing SWOT Analysis
Table 89. Sartorius Recent Developments
Table 90. GEA Group Company Details
Table 91. GEA Group Business Overview
Table 92. GEA Group Next-Generation Biomanufacturing Product and Services
Table 93. GEA Group Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 94. GEA Group Next-Generation Biomanufacturing SWOT Analysis
Table 95. GEA Group Recent Developments
Table 96. bbi-biotech Company Details
Table 97. bbi-biotech Business Overview
Table 98. bbi-biotech Next-Generation Biomanufacturing Product and Services
Table 99. bbi-biotech Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 100. bbi-biotech Next-Generation Biomanufacturing SWOT Analysis
Table 101. bbi-biotech Recent Developments
Table 102. Esco Group of Companies Company Details
Table 103. Esco Group of Companies Business Overview
Table 104. Esco Group of Companies Next-Generation Biomanufacturing Product and Services
Table 105. Esco Group of Companies Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 106. Esco Group of Companies Next-Generation Biomanufacturing SWOT Analysis
Table 107. Esco Group of Companies Recent Developments
Table 108. Solaris Biotechnology Company Details
Table 109. Solaris Biotechnology Business Overview
Table 110. Solaris Biotechnology Next-Generation Biomanufacturing Product and Services
Table 111. Solaris Biotechnology Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 112. Solaris Biotechnology Next-Generation Biomanufacturing SWOT Analysis
Table 113. Solaris Biotechnology Recent Developments
Table 114. PBS Biotech Company Details
Table 115. PBS Biotech Business Overview
Table 116. PBS Biotech Next-Generation Biomanufacturing Product and Services
Table 117. PBS Biotech Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 118. PBS Biotech Next-Generation Biomanufacturing SWOT Analysis
Table 119. PBS Biotech Recent Developments
Table 120. Applikon Biotechnology Company Details
Table 121. Applikon Biotechnology Business Overview
Table 122. Applikon Biotechnology Next-Generation Biomanufacturing Product and Services
Table 123. Applikon Biotechnology Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 124. Applikon Biotechnology Recent Developments
Table 125. Meissner Filtration Products Company Details
Table 126. Meissner Filtration Products Business Overview
Table 127. Meissner Filtration Products Next-Generation Biomanufacturing Product and Services
Table 128. Meissner Filtration Products Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 129. Meissner Filtration Products Recent Developments
Table 130. Shanghai Bailun Biotechnology Company Details
Table 131. Shanghai Bailun Biotechnology Business Overview
Table 132. Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Product and Services
Table 133. Shanghai Bailun Biotechnology Next-Generation Biomanufacturing Revenue in Next-Generation Biomanufacturing Business (2017-2022) & (US$ Million)
Table 134. Shanghai Bailun Biotechnology Recent Developments
Table 135. Next-Generation Biomanufacturing Market Trends
Table 136. Next-Generation Biomanufacturing Market Drivers
Table 137. Next-Generation Biomanufacturing Market Challenges
Table 138. Next-Generation Biomanufacturing Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next-Generation Biomanufacturing Sales Market Share by Type: 2021 VS 2028
Figure 2. Upstream Biomanufacturing Features
Figure 3. Downstream Biomanufacturing Features
Figure 4. Global Next-Generation Biomanufacturing Sales Market Share by Application: 2021 VS 2028
Figure 5. Biopharmaceutical Companies Case Studies
Figure 6. CMOs/CDMOs Case Studies
Figure 7. Research Institutions Case Studies
Figure 8. Next-Generation Biomanufacturing Report Years Considered
Figure 9. Global Next-Generation Biomanufacturing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Next-Generation Biomanufacturing Market Size 2017-2028 (US$ Million)
Figure 11. Global Next-Generation Biomanufacturing Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Next-Generation Biomanufacturing Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Next-Generation Biomanufacturing Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Next-Generation Biomanufacturing Market Share by Players in 2021
Figure 15. Global Top Next-Generation Biomanufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Biomanufacturing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Next-Generation Biomanufacturing Revenue in 2021
Figure 17. North America Next-Generation Biomanufacturing Revenue Market Share by Company in 2021
Figure 18. North America Next-Generation Biomanufacturing Revenue Market Share by Type (2017-2028)
Figure 19. North America Next-Generation Biomanufacturing Revenue Market Share by Application (2017-2028)
Figure 20. North America Next-Generation Biomanufacturing Revenue Share by Country (2017-2028)
Figure 21. U.S. Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Next-Generation Biomanufacturing Revenue Market Share by Company in 2021
Figure 24. Europe Next-Generation Biomanufacturing Revenue Market Share by Type (2017-2028)
Figure 25. Europe Next-Generation Biomanufacturing Revenue Market Share by Application (2017-2028)
Figure 26. Europe Next-Generation Biomanufacturing Revenue Share by Country (2017-2028)
Figure 27. Germany Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 28. France Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Next-Generation Biomanufacturing Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Next-Generation Biomanufacturing Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Next-Generation Biomanufacturing Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Next-Generation Biomanufacturing Revenue Share by Region (2017-2028)
Figure 36. China Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 39. India Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 41. Taiwan Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 45. Philippines Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 46. Vietnam Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Next-Generation Biomanufacturing Revenue Market Share by Company in 2021
Figure 48. Latin America Next-Generation Biomanufacturing Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Next-Generation Biomanufacturing Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Next-Generation Biomanufacturing Revenue Share by Country (2017-2028)
Figure 51. Mexico Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Next-Generation Biomanufacturing Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Next-Generation Biomanufacturing Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Next-Generation Biomanufacturing Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Next-Generation Biomanufacturing Revenue Share by Country (2017-2028)
Figure 58. Turkey Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 60. UAE Next-Generation Biomanufacturing Revenue (2017-2028) & (US$ Million)
Figure 61. Merck Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 63. Danaher Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 64. Eppendorf Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 65. Sartorius Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 66. GEA Group Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 67. bbi-biotech Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 68. Esco Group of Companies Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 69. Solaris Biotechnology Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 70. PBS Biotech Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 71. Applikon Biotechnology Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 72. Meissner Filtration Products Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 73. Shanghai Bailun Biotechnology Revenue Growth Rate in Next-Generation Biomanufacturing Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs